Results for tag: "Viibryd"

Viibryd is a medication used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). It is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the amount of serotonin in the brain. Viibryd is the brand name for vilazodone hydrochloride, a drug developed by Merck & Co. and approved by the U.S. Food and Drug Administration (FDA) in 2011. Viibryd is used to treat symptoms of depression and anxiety, such as low mood, difficulty concentrating, and feelings of worthlessness. It is also used to treat other mental health conditions, such as obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD). The Viibryd market is highly competitive, with many pharmaceutical companies offering similar medications. Some of the major players in the market include Merck & Co., Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Other companies, such as Sunovion Pharmaceuticals, Forest Laboratories, and Otsuka Pharmaceuticals, also offer medications for the treatment of mental disorders. Show Less Read more